Skip to Main Content

Bora Acquires Pyros Pharmaceuticals to Bolster Upsher-Smith Rare Disease Product Portfolio

Upsher-Smith Laboratories, LLC

Home
Capabilities
Products
Corporate Development
- Corporate Development
- NASPA Innovation Map
About Us
News
Plant C
Careers
Contact Us
- Contact Upsher-Smith
- Locations
800-654-2299

Capabilities
Products
Corporate Development
- Corporate Development
- NASPA Innovation Map
About Us
Careers
Contact Us
- Contact Upsher-Smith
- Locations

Plant C
News
800-654-2299

Sawai Q1 FY2018 Summary of Financial Results

August 14, 2018
Company News

Share:

Share on Facebook
Share on Twitter
Share on LinkedIn
Share via Email

DOWNLOAD PRESS RELEASE

Upsher-Smith Expands Portfolio with Sixth Product Launch in 2018
Sawai Q1 FY2018 Financial Results

Categories

Company News

Staying True to Our Roots

In 1919 our founder F.A. Upsher Smith harvested foxglove flowers on his Minnesota farm to extract the cardiac drug digitalis. In doing so, Upsher Smith yielded not only our first, foundational pharmaceutical product, but also a strong spirit of innovation that continues to inspire us today. Learn more about the history behind Upsher-Smith.

Facebook

© 2024 Upsher-Smith Laboratories, LLC. All Rights Reserved.

Site Credits
Terms and Conditions
Privacy Policy
Accessibility
Legal Notices

Careers

Join Our Team!

We’re hiring

Search Our Jobs

Close